Back
Novartis AG Vs. Novo Nordisk AS Industry Stock Comparison
Buy
62
NVS
Novartis AG
Last Price:
104.27
Seasonality Move:
1.51%
Sell
36
NVO
Novo Nordisk AS
Last Price:
105.10
Seasonality Move:
10.2%
Buy
62
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $103.85. The Score for NVS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
- The current Novo Nordisk AS [NVO] share price is $102.63. The Score for NVO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $103.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $102.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.
NVS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.82 | Sell |
Relative Strength Index (14 RSI): | 29.93 | Sell |
Chaikin Money Flow: | 1255993 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.1 - 113.22) | Sell |
Bollinger Bands (100): | (108.03 - 117.01) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.94 | Sell |
Relative Strength Index (14 RSI): | 35.3 | Sell |
Chaikin Money Flow: | 1803215 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.5 - 114.46) | Sell |
Bollinger Bands (100): | (113.58 - 136.66) | Sell |
NVS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.56 | Buy |
20-day SMA: | 107.1 | Sell |
50-day SMA: | 112.08 | Sell |
200-day SMA: | 106.39 | Sell |
8-day EMA: | 104.06 | Sell |
20-day EMA: | 106.69 | Sell |
50-day EMA: | 110.1 | Sell |
200-day EMA: | 107.77 | Sell |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 103.92 | Sell |
20-day SMA: | 107.77 | Sell |
50-day SMA: | 116.11 | Sell |
200-day SMA: | 127.9 | Sell |
8-day EMA: | 104.15 | Sell |
20-day EMA: | 107.6 | Sell |
50-day EMA: | 114.71 | Sell |
200-day EMA: | 120.64 | Sell |
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.
Novartis AG Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |